HCPCS J7699: NOC Inhalation Solution Administered via DME - OpenPayer

Summary & Overview

HCPCS J7699: NOC Inhalation Solution Administered via DME

HCPCS Level II code J7699 denotes non-oncology inhalation solutions administered through durable medical equipment (DME). This miscellaneous HCPCS drug code is used when a specific HCPCS Level II drug code is not available for an inhaled medication dispensed or billed with a nebulizer or other DME. Nationally, such codes matter because they affect coverage determinations, billing clarity, and payment processing for respiratory therapies in home and outpatient settings.

Key payers referenced in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for inhalation therapies delivered via DME, common billing considerations associated with miscellaneous inhalation drug codes, and the typical sites of service for these claims. The publication outlines benchmarks and policy-relevant updates where available, and highlights coding nuances that influence claim adjudication and reimbursement workflows. Where payor-specific coverage language is variable, the summary notes standard payer presence without prescribing actions for clinicians or billing staff.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareJ7699HCPCS Level IIinhalation solutiondurable medical equipmentnebulizer therapydrug billingrespiratory therapymiscellaneous drug codeoutpatient billing

Billing Code Overview

HCPCS Level II code J7699 represents non-oncology (NOC) drugs, inhalation solution administered through durable medical equipment (DME). This code is used to report inhalation medication formulations delivered via DME for respiratory therapy when a specific HCPCS drug code is not listed.

Service type: Inhalation drug administration via DME, typically involving aerosolized or nebulized solutions supplied for use with home or facility-based nebulizer equipment.

Typical site of service: Outpatient clinics, home health, and long-term care settings where durable medical equipment such as nebulizers or compressors are used to deliver inhaled medication.

Data not available in the input.

Clinical & Coding Specifications

Clinical Context

A typical patient is an adult with chronic obstructive pulmonary disease (COPD) or severe asthma who requires inhaled nebulized medication delivered through durable medical equipment (DME) such as a powered nebulizer or compressor. The patient presents either in a home health setting or at an outpatient infusion/respiratory therapy center for administration of a narcotic-containing inhalation solution or other controlled inhaled agent that is billed as a drug administered through DME under code J7699.

In the clinical workflow, the prescribing clinician documents the indication, selects the appropriate inhalation solution and DME, and writes an order for administration. A respiratory therapist or qualified nurse verifies patient identity, reviews allergies and recent vitals, assembles the nebulizer system, prepares the medication per manufacturer instructions, and administers the inhalation treatment while monitoring for adverse effects (respiratory depression, sedation, bronchospasm). The provider documents medication name, dose, route (inhalation via DME), start and stop times, patient tolerance, and any immediate interventions. Billing uses J7699 to report the drug when no specific HCPCS drug code exists for the inhalation solution and the service is delivered through DME. Appropriate place-of-service modifiers or condition modifiers are appended as indicated by payer policy.

Coding Specifications

Modifier	Description	When to Use

HCPCS Level II J0750: Emtricitabine-Tenofovir for HIV Pre-Exposure Prophylaxis

HCPCS-J3246-TIROFIBAN-INJECTION-025-MG

HCPCS J3246: Tirofiban HCl Injection, 0.25 mg

HCPCS-J8510-BUSULFAN-ORAL-2MG

HCPCS J8510: Busulfan, Oral 2 mg

HCPCS-J2501-PARICALCITOL-INJECTION-1-MCG

HCPCS J2501: Paricalcitol Injection, 1 mcg

HCPCS-J1643-HEPARIN-SODIUM-PFIZER-1000-UNITS

HCPCS J1643: Heparin Sodium (Pfizer), per 1000 Units

HCPCS-J1980-HYOSCYAMINE-SULFATE-INJECTION-025-MG

HCPCS Level II J1980: Injection, Hyoscyamine Sulfate up to 0.25 mg

HCPCS-J0207-AMIFOSTINE-INJECTION-500MG

HCPCS Level II J0207: Injection, Amifostine 500 mg

HCPCS-J3430-VITAMIN-K-INJECTION-PHYTONADIONE-PER-1MG

HCPCS Level II J3430: Injection, Phytonadione (Vitamin K), per 1 mg

HCPCS-J1448-TRILACICLIB-INJECTION-1MG

HCPCS J1448: Trilaciclib Injection, 1 mg

HCPCS-J7636-ATROPINE-INHALATION-COMPOUNDED-UNIT-DOSE

HCPCS J7636: Atropine Inhalation Solution, Compounded, Unit Dose

Showing 1–10 of 991

23

Taxonomy Code	Specialty	Notes
`Respiratory Therapist`	Respiratory Therapy	Primary clinician for administration, setup, and monitoring of nebulized therapy through DME.
`Pulmonologist`	Pulmonology	Prescribing specialist for chronic lung disease and inhaled therapeutics.
`Family Practitioner`	Family Medicine	Outpatient prescribers who manage chronic respiratory conditions and coordinate home therapies.
`Home Health Nurse`	Home Health Nursing	Delivers and documents administration in the patient’s home when part of a home health plan.
`Anesthesiologist`	Anesthesiology	Involved when inhalational agents are used under monitored anesthesia care or perioperative settings.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`J44.9`	Chronic obstructive pulmonary disease, unspecified	Frequent indication for nebulized inhalation therapies delivered via DME for bronchodilation and symptom control.
`J45.909`	Unspecified asthma, uncomplicated	Common diagnosis requiring nebulized medications administered through DME for acute exacerbations or maintenance in severe cases.
`J96.00`	Acute respiratory failure, unspecified whether with hypoxia or hypercapnia	Inpatient scenarios where inhalation solutions via DME are used as adjunctive therapy during respiratory failure management.
`R06.02`	Shortness of breath	Symptom-based reason for administration of inhalation solutions through nebulizer DME in urgent or outpatient settings.
`Z79.899`	Other long term (current) drug therapy	Denotes patients receiving ongoing inhaled medication regimens supplied via DME.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`94640`	Pressurized or non-pressurized inhalation treatment for acute airway obstruction, bronchodilator, administration by nebulizer or sequential nebulizer; initial service	Commonly performed for bronchodilator nebulization prior to or after administration of other inhaled agents through DME.
`94644`	Demonstration and/or evaluation of patient utilization of an aerosol generator, nebulizer, metered dose inhaler, or IPPB device	Used to document patient education on device use when initiating inhalation therapy via DME.
`94002`	Ventilation assist and management, initiation of pressure or volume preset ventilators for assisted or controlled breathing; hospital inpatient/observation, initial day	Relevant when inhalation therapy is part of broader respiratory support in an inpatient setting.
`99354`	Prolonged service in the office or other outpatient setting, requiring direct patient contact beyond the usual service; first hour	Billed when extended monitoring is required during prolonged inhalation drug administration in outpatient centers.
`99070`	Supplies and materials (except spectacles), provided by the physician over and above those usually included with the office visit	Used when additional non-covered supplies related to DME administration are furnished and billed separately.

OpenPayer